Brogan et al reported the Pediatric Glucocorticoid Toxicity Index (pGTI). This is based on the Glucocorticoid Toxicity Index (GTI). The authors are from multiple institutions in England, the United States and Canada.
Patient selection: <= 18 years old on glucocorticoids
Parameters:
(1) glucose metabolism
(2) blood pressure
(3) lipid metabolism
Parameter |
Finding |
Points |
glucose metabolism |
improvement in HbA1c AND decrease in medication |
-40 |
|
decrease in medication without improvement in HbA1c |
-29 |
|
improvement in HbA1c without decrease in medication |
-17 |
|
no significant change |
0 |
|
increase in HbA1c without decrease in medication |
17 |
|
increase in medication without increase in HbA1c |
29 |
|
increase in HbA1c AND increase in medication |
40 |
blood pressure |
improvement in blood pressure AND decrease in medication |
-38 |
|
decrease in medication without improvement of blood pressure |
-26 |
|
improvement in blood pressure without decrease in medication |
-15 |
|
no significant change |
0 |
|
increase in medication without increase in blood pressure |
15 |
|
increase in blood pressure without increase in medication |
26 |
|
increase in blood pressure AND increase in medication |
38 |
lipid metabolism |
decrease in LDL AND decrease in medications |
-33 |
|
decrease in medication without decrease in LDL |
-22 |
|
decrease in LDL without decrease in medication |
-11 |
|
no significant change |
0 |
|
increase in LDL without increase in medications |
11 |
|
increase in medications without increase in medications |
22 |
|
increase in LDL AND increase in medication |
33 |
subscore for metabolic and cardiovascular effects =
= SUM(points for all 3 parameters)
Interpretation:
• minimum score: -111
• maximum score: 111
• The higher the score the greater the metabolic and cardiovascular effects.
Specialty: Nutrition